NIH

The National Institutes of Health (NIH) is the “crown jewel of federal spending,” said Dr. Keith Yamamoto at a Capitol Hill briefing sponsored by the Coalition for the Life Sciences and the Congressional Biomedical Research Caucus on July 14 titled, NIH 101: An Introduction to the National Institutes of Health. Yamamoto, vice chancellor for research at the University of California, San Francisco and Research!America board member, was the featured speaker at the event, sponsored by the Coalition for Life Sciences and the Congressional Biomedical Research Caucus. He discussed the mission and budget of the NIH, as well as the rigorous scientific review process that ensures the budget achieves...
Dear Research Advocate, Former Congressman John Porter, Research!America’s esteemed Chair Emeritus, does not mince words in his Washington Post LTE today, cautioning against state-level education policies that could be misused to subvert science education. Treating knowledge that has been affirmed by years of scientific exploration as negotiable jeopardizes our nation’s ability to meet the challenges and seize the opportunities before us. It is a path to decline rather than progress. We cannot afford to shy away from straight talk about misguided policies. Fortunately for our nation, John never does. This afternoon, the House Labor-H Subcommittee, formerly chaired by Mr. Porter, “marked up...
Growing up in a rural community in upstate New York, I was not exposed to academic research at a young age. I knew I wanted to learn about diseases and the development of new treatments, even if I didn’t quite know exactly what that looked like at the time. A scholarship supported by the National Science Foundation (NSF) made it possible for me to attend Clarkson University in Potsdam, New York where I studied biology and chemistry. The Ronald E. McNair Scholarship, a STEM program that provides under-represented populations with access to research, provided funding for my studies at the University of Rochester where I worked in the Gorbunova laboratory studying the obscure naked mole rats...
Dr. Barbara McCrady recalls interviewing a woman who used to pass out on her bed before her husband came home from work. Suspecting something was amiss, the couple spent two years visiting sleep specialists and neurologists. Nobody suspected that the cause of her early slumbers was alcohol. The woman was drinking one liter of alcohol per day. McCrady, distinguished professor of psychology, University of New Mexico and Director, Center on Alcoholism, Substance Abuse, and Addictions, was among the speakers for a congressional briefing titled, The Changing Patterns of Women’s Drinking and Their Impact on Public Health, at the Rayburn House Office Building on June 22, 2017. “This underscores...
In the 18 months since former President Barack Obama announced the Cancer Moonshot Initiative (CMI), led by then-Vice President Joseph Biden, great strides have been made in the mission to accelerate the pace of cancer research. Among the goals of the initiative is to increase collaboration between public- and private-sector organizations, and government agencies to develop new methods of targeting cancer. CMI’s emphasis on innovation – specifically immunotherapy – and new approaches to research are especially important for rare cancers such as mesothelioma because traditional research and treatment methods often do not work. Immunotherapy, which uses a person’s own immune system to help...
Dear Research Advocate, Last Friday, I joined ASM CEO Stefano Bertuzzi and Georgetown McDonough School of Business professor and social marketing guru Bill Novelli in a lively session on advocacy for science. Bill emphasized the pivotal role strong leaders play in securing paradigm shifts such as a cultural shift in the value Americans assign to science and innovation. I thought of this when the welcome news broke that President Trump reappointed Dr. Francis Collins as NIH Director. Dr. Collins is second to none in his ability to connect the dots for the public and policymakers on the wide-ranging impact of research and innovation. More good news: the House E&C Committee passed the FDA...
Dear Research Advocate, Word of a plan to pass an FY18 omnibus bill in the House by the end of July has surfaced . The plan would require the House to rapidly draft, mark up and stitch together 12 appropriations bills. If House leadership takes this route, it is unclear what overall budget numbers they would work from; rumor has it they may adhere relatively closely to the “sequestration” budget caps established in 2011. Ironically, that would be significantly better than the president’s budget but, as I discussed last week , far worse than what is needed: an agreement to raise the caps and permit more budget flexibility. Call your members of Congress to make the case ; and follow up with a...
Dear Research Advocate, I hope you had an opportunity to read America’s ‘Miracle Machine’ is in desperate need of, well, a miracle in last Friday’s Washington Post. The authors, Eric S. Lander and Eric E. Schmidt, build a case for “investing in curiosity about the natural world” that exemplifies advocacy at its most compelling. The term “aha moment” may be overused, but it applies to this commentary as surely as it does to President Franklin Roosevelt’s remarks on the dedication of the NIH’s then-new campus in 1940, when he proclaimed: “We cannot be a strong nation unless we are a healthy nation. And so we must recruit not only men and materials, but also knowledge and science in the...
Dear Research Advocate, This Saturday, advocates will celebrate science at events in Washington, D.C., and hundreds of cities across the globe to call attention to the value of science -- how it impacts our health, economy and planet. I encourage you to participate in the March for Science in your local communities and help us raise awareness of scientific progress. Our new video featuring one of our science fellows will be shown on jumbotrons on the National Mall in D.C. during the event. Read more about this celebration in our Board Chair’s statement , my op-ed in the Miami Herald and an LTE by Research!America’s Suzanne Ffolkes in the Hartford Courant. The March is the beginning of a...
Dear Research Advocate, OMB has recommended cuts to FY17 appropriations , which would precede, if you will, the proposed FY18 cuts. As noted in our statement , these proposed cuts contradict worthy goals the President established for his tenure in office. They also fly in the face of public opinion. Fortunately, it appears Congress is not playing ball . Please use this editable message to say no to reductions and yes to passage of an FY17 omnibus bill. Reliable sources say the bill includes a $2 billion boost for NIH, as well as increases for CDC, FDA and NSF. The media is chock-full of commentary and quotes supporting investment in research and public health. A masterful Washington Post op...

Pages

Sidebar Quote

The capabilities are enormous, a little bit of research can pay off quite a bit in the long run.
Paul D’ Addario, retinitis pigmentosa patient